SCHEMBL6155174

SCHEMBL6155174

COC(=O)Cc1cccc(Oc2cccc(C=O)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.49
MAOA P21397 7/20 0.48
MAOB P27338 7/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.44
SRC P12931 1/20 0.43
ALDH1A1 P00352 2/20 0.43
POLB P06746 1/20 0.43
AKR1B1 P15121 1/20 0.43
ALOX5 P09917 1/20 0.42
ALOX5AP P20292 1/20 0.42
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
GAA P10253 1/20 0.41
GFER P55789 1/20 0.41
P2RX3 P56373 1/20 0.41
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1124720 0.88 SLC7A5 (0.56) SLC7A5MAOAMAOBNPC1RAB9A
SCHEMBL6154670 0.86 MAOA (0.46) MAOAMAOBNPC1RAB9ATDP1
SCHEMBL5213552 0.84 SLC7A5 (0.55) SLC7A5TDP1SMN1; SMN2ALDH1A1
SCHEMBL1798827 0.83 SLC7A5 (0.51) SLC7A5MAOAMAOBNPC1RAB9A
Methane SCHEMBL27618790 0.82 SLC7A5 (0.54) SLC7A5TDP1SMN1; SMN2ALDH1A1
SCHEMBL9152106 0.80 SLC1A5 (0.44) MAOAMAOBNPC1RAB9ATDP1
SCHEMBL28850543 0.79 MAOA (0.55) MAOAMAOBNPC1RAB9ATDP1
SCHEMBL12440458 0.79 P2RX3 (0.58) SLC7A5ALDH1A1P2RX3
SCHEMBL378705 0.79 SMN1; SMN2 (0.61) SLC7A5SMN1; SMN2ALDH1A1POLB
SCHEMBL31249652 0.79 SMN1; SMN2 (0.61) SLC7A5SMN1; SMN2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP SLC7A5 2145/4885MAOA 4410/4885MAOB 3660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.